MedPath

University of British Columbia

University of British Columbia logo
πŸ‡¨πŸ‡¦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ubc.ca

The Critical Care Recovery Program: Use of a Structured Clinic Visit to Reduce Adverse Drug Events in ICU Survivors

Not yet recruiting
Conditions
Post Intensive Care Syndrome (PICS)
Polypharmacy
Adverse Drug Events
Critical Care, Intensive Care
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
University of British Columbia
Target Recruit Count
3000
Registration Number
NCT06723860

Resistance Exercise Blood Flow Restriction

Not Applicable
Completed
Conditions
Skeletal Muscle Endurance
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
University of British Columbia
Target Recruit Count
29
Registration Number
NCT06724458
Locations
πŸ‡¨πŸ‡¦

Chan Gunn Pavilion, Vancouver, British Columbia, Canada

Continuous Vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids in Distress)

Not Applicable
Recruiting
Conditions
Critical Illness
Pediatric Intensive Care
Enteral Nutrition Therapy
Dietary Protein
First Posted Date
2024-12-06
Last Posted Date
2024-12-06
Lead Sponsor
University of British Columbia
Target Recruit Count
96
Registration Number
NCT06721923
Locations
πŸ‡¨πŸ‡¦

BC Childrens Hospital, Vancouver, British Columbia, Canada

Streamlining Care for Patients with Compression Neuropathies: the Carpal Tunnel Plus Pathway

Not yet recruiting
Conditions
Carpal Tunnel Syndrome (CTS)
First Posted Date
2024-12-05
Last Posted Date
2024-12-05
Lead Sponsor
University of British Columbia
Target Recruit Count
200
Registration Number
NCT06717477
Locations
πŸ‡¨πŸ‡¦

Vancouver General Hospital, Vancouver, British Columbia, Canada

FIRE-Diet: Food As an Intervention to Reduce the Effects of Woodsmoke Exposure on Respiratory Health

Not Applicable
Not yet recruiting
Conditions
Healthy Individuals
First Posted Date
2024-12-02
Last Posted Date
2024-12-02
Lead Sponsor
University of British Columbia
Target Recruit Count
48
Registration Number
NCT06711614
Locations
πŸ‡¨πŸ‡¦

University of British Columbia, Vancouver, British Columbia, Canada

Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study

Completed
Conditions
Multiple Sclerosis
Skin Cancer
Skin Cancer Melanoma
Skin Cancers - Basal Cell Carcinoma
Skin Cancer, Squamous Cell
Multiple Sclerosis (MS) - Relapsing-remitting
Interventions
First Posted Date
2024-11-26
Last Posted Date
2024-11-26
Lead Sponsor
University of British Columbia
Target Recruit Count
4000
Registration Number
NCT06705608

Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People with Spinal Cord Injury

Not Applicable
Not yet recruiting
Conditions
Spinal Cord Injury
First Posted Date
2024-11-26
Last Posted Date
2024-11-26
Lead Sponsor
University of British Columbia
Target Recruit Count
30
Registration Number
NCT06705790

The Effect of Peak Force At Long and Short Muscle Lengths and the Impact on Muscle Growth and Strength

Not Applicable
Conditions
Muscle Hypertrophy
Muscular Strength
First Posted Date
2024-10-30
Last Posted Date
2024-11-08
Lead Sponsor
University of British Columbia
Target Recruit Count
20
Registration Number
NCT06666127
Locations
πŸ‡¨πŸ‡¦

University of British Columbia, Vancouver, British Columbia, Canada

Monitoring Free Tissue Transfer Hemodynamics Using NIRS

Not Applicable
Not yet recruiting
Conditions
Oxygen Supply Absent
First Posted Date
2024-10-28
Last Posted Date
2024-10-28
Lead Sponsor
University of British Columbia
Target Recruit Count
60
Registration Number
NCT06661525
Locations
πŸ‡¨πŸ‡¦

Surrey Memorial Hospital, Surrey, British Columbia, Canada

πŸ‡¨πŸ‡¦

Vancouver General Hospital, Vancouver, British Columbia, Canada

Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients

Phase 2
Not yet recruiting
Conditions
Delirium - Postoperative
Cardiac Surgery
Cardiac Surgery Subjects
Orexin Antagonist
Feasibility Studies
Sleep
In-hospital Mortality
Interventions
Drug: Lemborexant 5 mg
Drug: Control (placebo) group
First Posted Date
2024-10-18
Last Posted Date
2024-11-27
Lead Sponsor
University of British Columbia
Target Recruit Count
60
Registration Number
NCT06648681
Locations
πŸ‡¨πŸ‡¦

St. Paul's Hospital, Vancouver, British Columbia, Canada

Β© Copyright 2025. All Rights Reserved by MedPath